FDA Approvals - Endo and Vernalis Plc Announce Three-Month Extension of PDUFA Date
Endo and Vernalis Plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA (RedNova)
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and Vernalis plc (LSE: VER) (NASDAQ: VNLS) today announced that the U.S.
Helpful friends in high places (The Star-Ledger)
WASHINGTON -- The drug in dustry may be facing tough times in the Democratic-controlled Congress, but it can still count on the backing of the Bush administration.